From continued globalization of the drug pipeline, to new levels of interactivity over the Web and social media, to electronic patient health records from clinical trials, how do you balance the need to get to market quickly with protecting your most valued resource—your intellectual property?
Scientific enterprise is collaborative by nature, yet it’s critical to protect the crown jewels of profit-generating trade secrets and patient identity information. Life sciences companies must maintain control of their critical data, while working with outside parties like contract research organizations, regulators, manufacturers, drug licensees, consultants, and marketers. This unique supply chain has become a target for advanced cyber threats.
Healthcare organizations are on the front lines when it comes to the need to safeguard their patients’ protected health information (PHI) and personal identity information (PII). Never has this been more crucial than now, with the healthcare industry undergoing a digital revolution: providers are undergoing health information technology initiatives to move to electronic health records (EHRs), consumers are filing insurance claims online and patients have increased access to their medical data.
The spectrum of laws and regulatory mandates that have been implemented to enhance the security of patient identity information has severely taxed the resources of many organizations in their quest to comply. So with constrained budgets and resources, privacy protection can be a daunting challenge.
Today’s advanced threats are led not just by individuals but by organizations, often with better technology than their targets. Cyber criminals are smarter, more persistent, and more focused on high-value assets. New attacks and methods of exploitation show that life sciences and healthcare companies have become targets of choice for deliberate and skilled attackers. Existing security solutions improve on the shortcomings of past products and services, but fall short.
It’s time for a new approach to secure sensitive data from advanced threats and the resulting data breaches.
Built on a patented Deep Session Inspection®, platform, Fidelis XPS™ is the industry's only network security solution capable of seeing, studying, and stopping advanced threats in real-time by uniquely working at the session-level where today’s threats occur—plugging the holes packet-level technologies leave open for custom attacks.
Fidelis XPS provides organizations with the network visibility, analysis, and control necessary to manage advanced threats, analyze forensics data more intelligently, and prevent data breaches., enabling them to achieve:
Contact us today to learn more about how Fidelis XPS is tested, installed, and delivering results for life sciences, pharmaceutical, and healthcare organizations around the globe.